Literature DB >> 1627787

Interleukin-6 in autoimmune disorders.

K Yoshizaki1, T Kuritani, T Kishimoto.   

Abstract

Interleukin-6, a pleiotropic cytokine, appears to play a key role as a physiologically functioning molecule in host defense mechanisms. Previous reports have suggested that dysregulated interleukin-6 production may be involved in lymph node hyperplasia, plasmacytosis, immunoglobulin hyperproduction, thrombocytosis, mesangial cell proliferation and acute phase response, all of which are frequently observed in autoimmune disorders. In this report, we discuss the possible involvement of interleukin-6 in the pathogenesis of a variety of autoimmune diseases and the regulatory mechanism of expression of the interleukin-6 gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627787

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  4 in total

1.  Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.

Authors:  A Brack; H L Rittner; B R Younge; C Kaltschmidt; C M Weyand; J J Goronzy
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 2.  Aryl hydrocarbon receptor and experimental autoimmune arthritis.

Authors:  Nam Trung Nguyen; Taisuke Nakahama; Tadamitsu Kishimoto
Journal:  Semin Immunopathol       Date:  2013-08-27       Impact factor: 9.623

Review 3.  Autoimmune findings resembling connective tissue disease in a patient with Castleman's disease.

Authors:  F Gohlke; E Märker-Hermann; S Kanzler; M Mitze; K H Meyer zum Büschenfelde
Journal:  Clin Rheumatol       Date:  1997-01       Impact factor: 3.650

4.  The Role of Th17 in Neuroimmune Disorders: A Target for CAM Therapy. Part III.

Authors:  Aristo Vojdani; Jama Lambert; Gottfried Kellermann
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.